Wednesday, February 28, 2024

2024 AI Prediction By Legend Who Picked Samsara, Gitlab & Crowdstrike

‌‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

 

Lung Cancer | Screening | Liquid Biopsy, 02/28/2024

National Cancer Institute

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

Cancer Information Highlights
From the National Cancer Institute
Updating you about cancer causes, prevention, screening, treatment, coping, and more
 
New from NCI
Targeted Drug Expands Treatment Options for Lung Cancers with ROS1 Fusions
stylized lungs with a tumor   The results of the clinical trial that led to the Food and Drug Administration's (FDA) 2023 approval of repotrectinib (Augtyro) for lung cancers with ROS1 fusions have been published. The drug shrank tumors in 80% of people receiving it as first-line treatment.

Read More
Research Network to Evaluate Emerging Cancer Screening Technologies
man sits on a hospital bed while a health care provider rubs the crook of his elbow with alcohol   NCI has launched a clinical trials network to study emerging technologies for cancer screening. In 2024, the network will launch a pilot study, known as the Vanguard Study on Multi-Cancer Detection, to inform the design of a larger trial of multi-cancer detection tests.

Read More
Priming Agents May Improve Liquid Biopsies
Drawing shows 2 test tubes, before priming agent and after priming agent. The after test tubs has more circulating tumor DNA.   Using two different techniques, researchers showed they could briefly boost circulating tumor DNA (ctDNA) levels in the blood of mice with tumors. With more ctDNA in collected blood draws, a liquid biopsy could better detect cancer, the research team found.

Read More
A Simple Tool Is Saving Lives of Children with Cancer in Latin America

A system for catching treatment-related complications in children with cancer has proven to be highly effective in many Latin American hospitals. An NCI-funded study aims to help these early warning systems last.

Read More

Lymphedema

Lymphedema, the buildup of lymph fluid in tissues causing swelling, affects function and quality of life. Learn about ways to prevent and treat it with exercise, compression, laser and drug therapy, surgery, massage, and more on this expert-reviewed page.

Read More

New Approval for Lung Cancer

FDA approval for osimertinib (Tagrisso) has been expanded. It is now approved to be used with chemotherapy as the first treatment for non-small cell lung cancer that has an abnormal EGFR gene and has spread.

Read More

Childhood Brain Tumors

Our pages on DIPG (diffuse intrinsic pontine glioma), childhood ependymoma, and childhood glioma (including astrocytoma) have a new look. The pages cover causes and risk factors, symptoms, screening, diagnosis, prognosis, stages, and treatment.

 
Contact Us
cancer information specialist   Information specialists at NCI's Cancer Information Service (CIS), NCI's contact center, are available to help answer your cancer-related questions in English and Spanish. This page tells you how to reach us by phone, chat, or email.

 

This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: National Cancer Institute · BG 9609 MSC 9760 · 9609 Medical Center Drive · Bethesda, MD 20892 GovDelivery logo

My blueprint for investing in dividend stocks

How do I pick “ultimate” dividend stocks?
 
   
     
I have never seen a more reliable, safe approach to income than with dividend stocks.

Now don’t get me wrong…

I don’t blindly go pick up any dividend paying stock – and you shouldn’t either…

Because the truth is, most of them have pretty low yields.
 
One of the things to look for is a high enough yield.

But dividend yield isn’t the be all, end all.

What good is a stock with a high yield if it crashes and we lose most of our investment at the same time?

That’s why it’s important to have a process for selecting what I like to call “ultimate” dividend stocks.

Click here to get my three-step checklist to building an income producing portfolio of dividend stocks.

Plus get my seven best dividend stocks for free.

To your trading success,

Nate
   
 

$150 Oil

 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 
Shield

AN OXFORD CLUB PUBLICATION

 
Liberty Through Wealth

THE SHORTEST WAY TO A RICH LIFE

$150 Oil

Marc Lichtenfeld | Chief Income Strategist | The Oxford Club

Marc Lichtenfeld

Oil is surging right now.

Saudi and Russian supply cuts drove oil prices above $90 a barrel - the highest level in 10 months.

Now, Bloomberg reports the war between Israel and Hamas could drive oil to $150!

While oil and gas stocks will benefit from this price surge...

There's a much better way to play it.

It's NOT an oil stock, futures, or anything you've likely heard about.

Rather, it's an unusual way to potentially bank huge monthly income from the oil and gas markets.

It's a secret so powerful that one man used it to turn a single $1,000 investment into a $100,000 income stream over fifty years!

All the details are right here:

Marc standing infront of Oil Rig

Good investing,

Marc

The 96% win rate options trade no one's talking about

 
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌&nbs p;‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ &z wnj; ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌  ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ &zwn j; ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ 
daytradespy-pod-email-header2
 
Hugh GrossmanFellow Investor,

I win a whopping 96% of my trades. My unique way of trading options almost never loses.

This means my system is reliable, consistent, and dependable.

Which is rare in the options world.

Who else do you know wins 96% of the time?

Yet it’s not something that requires you to be an expert (beginners can make these trades easily).

It’s not low-paying covered calls.

It’s not complicated naked puts or iron condors.

It’s not watching your screen for hours to trade this way.

Here’s what it IS: 

A simple, consistent 96% winning system that’s the most unique way of trading options you’ll ever find.

And no one else teaches this but me.

Today, I’m offering you the chance to use it with me.

If you’d like to see how to win up to 96% of your options trades, join me by clicking the link below.

Click Here for 96% Options Winners

If you’re interested, though, I urge you to act fast. I limit the number of people I share this with so that everyone maximizes profits.

This time around, I’m only showing it to the first 37 people who respond.

To make sure you’re one of them, click here now.
 
Click Here to Find Out More >
Yours for higher profits,
Hugh Grossman
Hugh Grossman
Trading Director, DayTradeSPY
 
Eagle Financial Publications - Eagle Products, LLC. - a Salem Communications Holding Company
122 C Street NW, Suite 515 | Washington, D.C. 20001
© Eagle Financial Publications. All rights reserved.

Welcome to Power Trends!

Hello, Thank you for subscribing! You will receive your first copy of Power Trends soon. We look forward ...